Cargando…

252. Increased incidence rates of positive blood cultures shortly after chemotherapy treatment initiation among individuals treated for solid malignant tumours

BACKGROUND: Cancer treatments suppress immune function and are associated with increased risk of infections, but the overall burden of serious infectious diseases in treated patients has not been clearly elucidated. METHODS: All patients treated for solid malignant tumours with curative intent radio...

Descripción completa

Detalles Bibliográficos
Autores principales: Roen, Ashley O, Terrones-Campos, Cynthia, Mocroft, Amanda, Andersen, Michael Asger, Helleberg, Marie, Niemann, Carsten Utoft, Daugaard, Gedske, Specht, Lena, Reekie, Joanne, Lundgren, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777387/
http://dx.doi.org/10.1093/ofid/ofaa439.296
_version_ 1783630890934468608
author Roen, Ashley O
Terrones-Campos, Cynthia
Mocroft, Amanda
Andersen, Michael Asger
Helleberg, Marie
Niemann, Carsten Utoft
Daugaard, Gedske
Specht, Lena
Reekie, Joanne
Lundgren, Jens
author_facet Roen, Ashley O
Terrones-Campos, Cynthia
Mocroft, Amanda
Andersen, Michael Asger
Helleberg, Marie
Niemann, Carsten Utoft
Daugaard, Gedske
Specht, Lena
Reekie, Joanne
Lundgren, Jens
author_sort Roen, Ashley O
collection PubMed
description BACKGROUND: Cancer treatments suppress immune function and are associated with increased risk of infections, but the overall burden of serious infectious diseases in treated patients has not been clearly elucidated. METHODS: All patients treated for solid malignant tumours with curative intent radiotherapy (RT) and/or standard first line chemotherapy (C) at the Department of Oncology at Rigshospitalet between 01/1/2010 to 31/12/2016 were included. Patients were followed from treatment initiation to new cancer treatment, end of follow up or death whichever came first. We calculated incidence rates (IR) of positive blood culture (PBC) per 1000 person years follow up using Kaplan-Meier methods, and examined the proportion who died within 30 days of PBC. RESULTS: 13,275 individuals were included, 4,372 (33%), 6,349 (48%), and 2,554 (19%) treated with RT, C, or concomitant RT&C, respectively, contributing 21,493 person years follow-up. 6,930 (52%) were female, the median (IQR) age was 63 (53, 70), and the most common cancer diagnoses were breast (n = 2,593 [19%]), colorectal (n=1,422 [11%]), and stomach (n=1,246 [9%]). Overall, 564 individuals (4%) experienced 746 unique episodes of PBC, 188, 408, and 150 events in 143, 311 and 110 individuals treated with RT, C, and RT&C, of which 49 (26%), 104 (25%), 38 (25%) died within 30 days of PBC, respectively. IR of PBC significantly varied by treatment: 13.0 (95% confidence interval 11.1, 15.4), 43.9 (39.3, 49.0) and 32.0 (26.5, 38.5) per 1000 person-years follow up in the RT, C and RT&C groups, respectively (IR ratio = 3.36 (2.75, 4.10) and 2.45 (1.91, 3.14) for C and RT&C compared to RT, respectively) and time since treatment (figure). Escherichia coli (n=185, 25%), Staphylococcus aureus (n=102, 14%), Klebsiella pneumoniae (n=76, 10%), Enterococcus faecium (n=48, 6%), and Enterococcus faecalis (n= 37, 5%) were the top 5 microorganisms identified and did not vary by treatment category, p = 0.11, there were 31 (4%) cases of Candida. Incidence rate of positive blood culture (PBC) by time since treatment initiation (0–3 months, 0–6 months and >6 months) and the proportion who died within 30 days of PBC by treatment type among individuals treated for solid malignant tumours with radiotherapy [RT], chemotherapy [C] and concomitant RT&C at Department of Oncology at Rigshospitalet, University of Copenhagen between 01/1//2010 to 31/12/2016. [Image: see text] CONCLUSION: PBCs are seen more often within 3 – 6 months after C than after RT alone. PBCs are not common, but when they occur, mortality is high. More precise risk factors for PBC and prophylactic means and empiric treatments in selected high-risk patients should be investigated. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7777387
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77773872021-01-07 252. Increased incidence rates of positive blood cultures shortly after chemotherapy treatment initiation among individuals treated for solid malignant tumours Roen, Ashley O Terrones-Campos, Cynthia Mocroft, Amanda Andersen, Michael Asger Helleberg, Marie Niemann, Carsten Utoft Daugaard, Gedske Specht, Lena Reekie, Joanne Lundgren, Jens Open Forum Infect Dis Poster Abstracts BACKGROUND: Cancer treatments suppress immune function and are associated with increased risk of infections, but the overall burden of serious infectious diseases in treated patients has not been clearly elucidated. METHODS: All patients treated for solid malignant tumours with curative intent radiotherapy (RT) and/or standard first line chemotherapy (C) at the Department of Oncology at Rigshospitalet between 01/1/2010 to 31/12/2016 were included. Patients were followed from treatment initiation to new cancer treatment, end of follow up or death whichever came first. We calculated incidence rates (IR) of positive blood culture (PBC) per 1000 person years follow up using Kaplan-Meier methods, and examined the proportion who died within 30 days of PBC. RESULTS: 13,275 individuals were included, 4,372 (33%), 6,349 (48%), and 2,554 (19%) treated with RT, C, or concomitant RT&C, respectively, contributing 21,493 person years follow-up. 6,930 (52%) were female, the median (IQR) age was 63 (53, 70), and the most common cancer diagnoses were breast (n = 2,593 [19%]), colorectal (n=1,422 [11%]), and stomach (n=1,246 [9%]). Overall, 564 individuals (4%) experienced 746 unique episodes of PBC, 188, 408, and 150 events in 143, 311 and 110 individuals treated with RT, C, and RT&C, of which 49 (26%), 104 (25%), 38 (25%) died within 30 days of PBC, respectively. IR of PBC significantly varied by treatment: 13.0 (95% confidence interval 11.1, 15.4), 43.9 (39.3, 49.0) and 32.0 (26.5, 38.5) per 1000 person-years follow up in the RT, C and RT&C groups, respectively (IR ratio = 3.36 (2.75, 4.10) and 2.45 (1.91, 3.14) for C and RT&C compared to RT, respectively) and time since treatment (figure). Escherichia coli (n=185, 25%), Staphylococcus aureus (n=102, 14%), Klebsiella pneumoniae (n=76, 10%), Enterococcus faecium (n=48, 6%), and Enterococcus faecalis (n= 37, 5%) were the top 5 microorganisms identified and did not vary by treatment category, p = 0.11, there were 31 (4%) cases of Candida. Incidence rate of positive blood culture (PBC) by time since treatment initiation (0–3 months, 0–6 months and >6 months) and the proportion who died within 30 days of PBC by treatment type among individuals treated for solid malignant tumours with radiotherapy [RT], chemotherapy [C] and concomitant RT&C at Department of Oncology at Rigshospitalet, University of Copenhagen between 01/1//2010 to 31/12/2016. [Image: see text] CONCLUSION: PBCs are seen more often within 3 – 6 months after C than after RT alone. PBCs are not common, but when they occur, mortality is high. More precise risk factors for PBC and prophylactic means and empiric treatments in selected high-risk patients should be investigated. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7777387/ http://dx.doi.org/10.1093/ofid/ofaa439.296 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Roen, Ashley O
Terrones-Campos, Cynthia
Mocroft, Amanda
Andersen, Michael Asger
Helleberg, Marie
Niemann, Carsten Utoft
Daugaard, Gedske
Specht, Lena
Reekie, Joanne
Lundgren, Jens
252. Increased incidence rates of positive blood cultures shortly after chemotherapy treatment initiation among individuals treated for solid malignant tumours
title 252. Increased incidence rates of positive blood cultures shortly after chemotherapy treatment initiation among individuals treated for solid malignant tumours
title_full 252. Increased incidence rates of positive blood cultures shortly after chemotherapy treatment initiation among individuals treated for solid malignant tumours
title_fullStr 252. Increased incidence rates of positive blood cultures shortly after chemotherapy treatment initiation among individuals treated for solid malignant tumours
title_full_unstemmed 252. Increased incidence rates of positive blood cultures shortly after chemotherapy treatment initiation among individuals treated for solid malignant tumours
title_short 252. Increased incidence rates of positive blood cultures shortly after chemotherapy treatment initiation among individuals treated for solid malignant tumours
title_sort 252. increased incidence rates of positive blood cultures shortly after chemotherapy treatment initiation among individuals treated for solid malignant tumours
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777387/
http://dx.doi.org/10.1093/ofid/ofaa439.296
work_keys_str_mv AT roenashleyo 252increasedincidenceratesofpositivebloodculturesshortlyafterchemotherapytreatmentinitiationamongindividualstreatedforsolidmalignanttumours
AT terronescamposcynthia 252increasedincidenceratesofpositivebloodculturesshortlyafterchemotherapytreatmentinitiationamongindividualstreatedforsolidmalignanttumours
AT mocroftamanda 252increasedincidenceratesofpositivebloodculturesshortlyafterchemotherapytreatmentinitiationamongindividualstreatedforsolidmalignanttumours
AT andersenmichaelasger 252increasedincidenceratesofpositivebloodculturesshortlyafterchemotherapytreatmentinitiationamongindividualstreatedforsolidmalignanttumours
AT hellebergmarie 252increasedincidenceratesofpositivebloodculturesshortlyafterchemotherapytreatmentinitiationamongindividualstreatedforsolidmalignanttumours
AT niemanncarstenutoft 252increasedincidenceratesofpositivebloodculturesshortlyafterchemotherapytreatmentinitiationamongindividualstreatedforsolidmalignanttumours
AT daugaardgedske 252increasedincidenceratesofpositivebloodculturesshortlyafterchemotherapytreatmentinitiationamongindividualstreatedforsolidmalignanttumours
AT spechtlena 252increasedincidenceratesofpositivebloodculturesshortlyafterchemotherapytreatmentinitiationamongindividualstreatedforsolidmalignanttumours
AT reekiejoanne 252increasedincidenceratesofpositivebloodculturesshortlyafterchemotherapytreatmentinitiationamongindividualstreatedforsolidmalignanttumours
AT lundgrenjens 252increasedincidenceratesofpositivebloodculturesshortlyafterchemotherapytreatmentinitiationamongindividualstreatedforsolidmalignanttumours